rs114014006

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032444.4(SLX4):​c.2824G>C​(p.Glu942Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00496 in 1,614,066 control chromosomes in the GnomAD database, including 141 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E942V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.018 ( 69 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 72 hom. )

Consequence

SLX4
NM_032444.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.31

Publications

11 publications found
Variant links:
Genes affected
SLX4 (HGNC:23845): (SLX4 structure-specific endonuclease subunit) This gene encodes a protein that functions as an assembly component of multiple structure-specific endonucleases. These endonuclease complexes are required for repair of specific types of DNA lesions and critical for cellular responses to replication fork failure. Mutations in this gene were found in patients with Fanconi anemia. [provided by RefSeq, Sep 2016]
SLX4 Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group P
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028381348).
BP6
Variant 16-3590814-C-G is Benign according to our data. Variant chr16-3590814-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235273.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0531 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLX4NM_032444.4 linkc.2824G>C p.Glu942Gln missense_variant Exon 12 of 15 ENST00000294008.4 NP_115820.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLX4ENST00000294008.4 linkc.2824G>C p.Glu942Gln missense_variant Exon 12 of 15 5 NM_032444.4 ENSP00000294008.3

Frequencies

GnomAD3 genomes
AF:
0.0176
AC:
2676
AN:
152198
Hom.:
69
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0550
Gnomad AMI
AF:
0.0428
Gnomad AMR
AF:
0.00726
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00746
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00222
Gnomad OTH
AF:
0.0196
GnomAD2 exomes
AF:
0.00648
AC:
1629
AN:
251264
AF XY:
0.00556
show subpopulations
Gnomad AFR exome
AF:
0.0534
Gnomad AMR exome
AF:
0.00593
Gnomad ASJ exome
AF:
0.00457
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00254
Gnomad OTH exome
AF:
0.00539
GnomAD4 exome
AF:
0.00365
AC:
5330
AN:
1461750
Hom.:
72
Cov.:
36
AF XY:
0.00366
AC XY:
2665
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.0547
AC:
1833
AN:
33480
American (AMR)
AF:
0.00597
AC:
267
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00394
AC:
103
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00752
AC:
649
AN:
86254
European-Finnish (FIN)
AF:
0.000394
AC:
21
AN:
53302
Middle Eastern (MID)
AF:
0.0189
AC:
109
AN:
5768
European-Non Finnish (NFE)
AF:
0.00178
AC:
1983
AN:
1111992
Other (OTH)
AF:
0.00604
AC:
365
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
385
770
1156
1541
1926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0176
AC:
2681
AN:
152316
Hom.:
69
Cov.:
32
AF XY:
0.0172
AC XY:
1284
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0550
AC:
2287
AN:
41570
American (AMR)
AF:
0.00725
AC:
111
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00374
AC:
13
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00705
AC:
34
AN:
4824
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10628
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00222
AC:
151
AN:
68016
Other (OTH)
AF:
0.0190
AC:
40
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
128
256
385
513
641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00462
Hom.:
6
Bravo
AF:
0.0188
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.0505
AC:
222
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.00760
AC:
923
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.00513
EpiControl
AF:
0.00385

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Aug 24, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:3
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 31, 2012
Leiden Open Variation Database
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:curation

Curator: Arleen D. Auerbach. Submitter to LOVD: Janine Bakker. -

Fanconi anemia complementation group P Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 22, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
7.4
DANN
Benign
0.90
DEOGEN2
Benign
0.097
T
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.38
T
MetaRNN
Benign
0.0028
T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
1.8
L
PhyloP100
1.3
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.78
N
REVEL
Benign
0.12
Sift
Benign
0.13
T
Sift4G
Benign
0.27
T
Polyphen
0.99
D
Vest4
0.13
MVP
0.32
MPC
0.15
ClinPred
0.0095
T
GERP RS
4.0
Varity_R
0.13
gMVP
0.16
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114014006; hg19: chr16-3640815; API